Cardiology

Cardiology CME

Earn Cardiology CME that fits how you practice. ReachMD offers practical, on-demand Cardiology CME/CE designed for cardiologists, fellows, APPs, and the full cardiovascular care team. Explore short, case-based activities and expert discussions across heart failure, interventional cardiology, electrophysiology, imaging, prevention, and more. Use this page to find your next activity fast. Browse learning tracks, jump into trending topics, or choose a series from our partner academies and clinical-practice resources. New activities are added regularly, so you can stay current with emerging evidence and evolving standards of care while earning credit on your schedule.

Start an activity below to earn credit or browse by topic to find the Cardiology CME most relevant to your practice.

653

LikeLikedUnlike

1-15 of 173

Hypertrophic Cardiomyopathy: Moving From Monitoring to Action in the Era of Myosin Inhibitors
Cardiology
Hypertrophic Cardiomyopathy: Moving From Monitoring to Action in the Era of Myosin Inhibitors
- Joseph Rossano, MD
  Peer
Beyond Steroidal MRAs: The Nonsteroidal MRA Lens in HF
CME/CE
Beyond Steroidal MRAs: The Nonsteroidal MRA Lens in HF
- Maria Pabon, MD
  Peer
- Robert J. Mentz, MD, FHFSA, FACC
  Peer
0.25 credits
MinuteCE®
Modern Obstructive HCM Care: From Unmet Needs to Individualized Myosin Inhibitor Therapy
- Ahmad Masri, MD, MS
  Peer
- Michael Nassif, MD, MSc
  Peer
- Anjali Owens, MD
  Peer
1.00 credits 6 episodes
NEW EPISODE
Cracking the Code of Obstruction: Unmet Needs in oHCM
MinuteCE®
Cracking the Code of Obstruction: Unmet Needs in oHCM
- Michael Nassif, MD, MSc
  Peer
1.00 program credits
When ß-Blockers Fall Short in oHCM: Time for a New Approach?
MinuteCE®
When ß-Blockers Fall Short in oHCM: Time for a New Approach?
- Ahmad Masri, MD, MS
  Peer
- Anjali Owens, MD
  Peer
1.00 program credits
NEW EPISODE
Molecular Precision: How Myosin Inhibitors Redefine Control
MinuteCE®
Molecular Precision: How Myosin Inhibitors Redefine Control
- Ahmad Masri, MD, MS
  Peer
- Anjali Owens, MD
  Peer
1.00 program credits
advertisement
NEW EPISODE
Redefining oHCM Care: Efficacy and Safety of Myosin Inhibitors
MinuteCE®
Redefining oHCM Care: Efficacy and Safety of Myosin Inhibitors
- Michael Nassif, MD, MSc
  Peer
- Anjali Owens, MD
  Peer
1.00 program credits
NEW EPISODE
From Evidence to Action: Integrating Emerging Myosin Inhibitors Into oHCM Treatment Plans
MinuteCE®
From Evidence to Action: Integrating Emerging Myosin Inhibitors Into oHCM Treatment Plans
- Michael Nassif, MD, MSc
  Peer
- Anjali Owens, MD
  Peer
1.00 program credits
NEW EPISODE
From Beta-Blockers to Myosin Inhibitors: Initial Decision-Making in Obstructive HCM
MinuteCE®
From Beta-Blockers to Myosin Inhibitors: Initial Decision-Making in Obstructive HCM
- Ahmad Masri, MD, MS
  Peer
- Anjali Owens, MD
  Peer
1.00 program credits
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
CME/CE
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
- Ellie Kelepouris, MD, FACP, FAHA
  Peer
- Nihar R. Desai, MD, MPH
  Peer
0.25 credits
MinuteCE®
The Ambulatory HFrEF Blind Spot: Proactively Reducing CV Mortality Risk Despite Optimized GDMT
- Carolyn S. P. Lam, MBBS, PhD
  Peer
- Javed Butler, MD
  Peer
- Prof. Dr. Johann Bauersachs
  Peer
0.75 credits 5 episodes
When GDMT Isn’t Enough: Understanding Residual Risk in Patients with HFrEF
MinuteCE®
When GDMT Isn’t Enough: Understanding Residual Risk in Patients with HFrEF
- Javed Butler, MD
  Peer
0.75 program credits
advertisement
GDMT Is Working Fine, Why Add More Therapies? The Clinical Rationale for Layering Therapies in Patients with HFrEF
MinuteCE®
GDMT Is Working Fine, Why Add More Therapies? The Clinical Rationale for Layering Therapies in Patients with HFrEF
- Javed Butler, MD
  Peer
- April W. Armstrong, MD, MPH
  Peer
0.75 program credits
Do Not Delay: Timing, Triggers, and Identifying the Right Patient for Additional Therapies in HFrEF
MinuteCE®
Do Not Delay: Timing, Triggers, and Identifying the Right Patient for Additional Therapies in HFrEF
- Prof. Dr. Johann Bauersachs
  Peer
- Javed Butler, MD
  Peer
0.75 program credits
Evidence at a Glance: The Totality of Evidence Impacting Clinical Decision-Making in Patients with HFrEF Without a Recent Worsening Event
MinuteCE®
Evidence at a Glance: The Totality of Evidence Impacting Clinical Decision-Making in Patients with HFrEF Without a Recent Worsening Event
- Prof. Dr. Johann Bauersachs
  Peer
- Carolyn S. P. Lam, MBBS, PhD
  Peer
0.75 program credits